OhioHealth - Hairy cell leukemia

Links shared publicly online about this topic.

  • 413
    total visits

OhioHealth - Hairy cell leukemia

ohiohealth.com

OhioHealth - Hairy cell leukemia

View full resource at ohiohealth.com

Tags: Allergies, Asthma, Allergic Asthma, Leukemia, Hairy Cell Leukemia, COPD Medication, Children's Health, Proventil

  • Share

Most Recently Shared on March 25, 2011 at 4:40 pm By:

Ohio_Health OhioHealth

Do you have a child taking albuterol for mild allergic asthma? OhioHealthy Tip: Albuterol side effects in kids, http://ow.ly/4mnfP

1 year ago...

St. Jude Children's Research Hospital | St. Jude Tribute

fundraising.stjude.org — “St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with pediatric cancer and other catastrophic diseases. Founded by late entertainer Danny Thomas and located in Memphis, Tennessee, St. Jude is the premiere institution for treating such life-threatening illnesses as leukemia, brain tumors, solid tumors, sickle cell disease, osteogenesis imperfecta (OI) and other childhood infectious diseases. All St. Jude treatment proView full resource at fundraising.stjude.org

  • View Related
  • Share

Most Recently Shared on March 28, 2012 at 2:05 pm By:

StJude St. Jude Children's Hospital and Hospital

Issac's family met their #Hoops4StJude Week goal! Please help them double their goal in Isaac's honor by Friday: http://t.co/JhmI0RZx

3 weeks ago...

Molecular Cancer | Abstract | RhoA: A therapeutic target for chronic myeloid leukemia

molecular-cancer.com — “Chronic Myeloid Leukemia (CML) is a malignant pluripotent stem cells disorder of myeloid cells. In CML patients, polymorphonuclear leukocytes (PMNL) the terminally differentiated cells of myeloid series exhibit defects in several actin dependent functions such as adhesion, motility, chemotaxis, agglutination, phagocytosis and microbicidal activities. A definite and global abnormality was observed in stimulation of actin polymerization in CML PMNL. Signalling molecules ras and rhoGTPases regulateView full resource at molecular-cancer.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 12:30 pm By:

Cancer Cells Reprogrammed With Low Doses Of Epigenetic Drugs

medicalnewstoday.com — “Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. TheView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 7:05 am By:

mnt_leukemia MNT Leukemia Health News

Cancer Cells Reprogrammed With Low Doses Of Epigenetic Drugs http://t.co/dj68HJMj #lymphoma #leukemia

3 weeks ago...

Drug makes leukemia more vulnerable to chemo

labspaces.net — “Doctors at Washington University School of Medicine in St. Louis have shown that a new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells. Instead of attacking these cells directly, the drug helps drive them out of the bone marrow and into the bloodstream, where they are more vulnerable to chemotherapy.View full resource at labspaces.net

  • View Related
  • Share

Most Recently Shared on March 21, 2012 at 1:00 pm By:

LabSpaces Brian Krueger Health News

Drug makes leukemia more vulnerable to chemo - http://t.co/FOdCqvTJ

4 weeks ago...

Plerixafor Makes Leukemia More Vulnerable To Chemo

medicalnewstoday.com — “Doctors at Washington University School of Medicine in St. Louis have shown that a new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells.View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 21, 2012 at 8:05 am By:

Drug makes leukemia more vulnerable to chemo

eurekalert.org — “Doctors at Washington University School of Medicine in St. Louis have shown that a new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells. Instead of attacking these cells directly, the drug helps drive them out of the bone marrow and into the bloodstream, where they are more vulnerable to chemotherapy.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 2:40 pm By:

BoneCancer_OW Bone Cancer OW OW Health

Drug makes leukemia more vulnerable to chemo: ( Washington University School of Medicine ) Doctors at Washington... http://t.co/xR7D9iPm

4 weeks ago...

Drug Makes Leukemia More Vulnerable to Chemo

newswise.com — “Doctors at Washington University School of Medicine in St. Louis have shown that a new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells. Instead of attacking these cells directly, the drug helps drive them out of the bone marrow and into the bloodstream, where they are more vulnerable to chemotherapy.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 1:50 pm By:

mednewswise Thom Canalichio Health News

#health news: Drug Makes Leukemia More Vulnerable to Chemo http://t.co/H5JY1lRU

4 weeks ago...

Drug makes leukemia more vulnerable to chemo

medicalxpress.com — “(Medical Xpress) -- Doctors at Washington University School of Medicine in St. Louis have shown that a new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells. Instead of attacking these cells directly, the drug helps drive them out of the bone ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 10:58 am By:

30% Of Patients With Non Small Cell Lung Cancer Present Alterations In BRG1

medicalnewstoday.com — “Retinoic acid (vitamin A) and steroids are hormones found in our body that protect against oxidative stress, reduce inflammation and are involved in cellular differentiation processes. One of theView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 19, 2012 at 7:05 am By:

mnt_breastcance MNT Breast Cancer Health News

30% Of Patients With Non Small Cell Lung Cancer Present Alterations In BRG1 http://t.co/k1a5Usgi #breastcancer

4 weeks ago...

Infectious Disease News - Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib |3982529

mdlinx.com — “Infectious Disease Medical Article: Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinibView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 17, 2012 at 3:39 am By:

MDLinx Sandeep Pulim MD Health Communicator, Physician, and Doctor

Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by d... http://t.co/Mt0FHlEd #ID

4 weeks ago...

Specific Mutations in AML Affect Response to Therapy - ONA

oncologynurseadvisor.com — “Also, bone marrow cells in myelodysplastic syndromes, secondary AML are clonal.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 11:30 pm By:

Scientists map genetic evolution of leukemia - National Cancer Institute

cancer.gov — “By mapping the evolution of cancer cells in patients with myelodysplastic syndromes who later died of leukemia, Timothy Graubert, MD, and Matthew Walter, MD, have found clues to suggest that targeted cancer drugs should be aimed at mutations that developView full resource at cancer.gov

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 5:49 pm By:

In Leukemia, Discovery Of Mer Protein In Cancer Cells' Nuclei Offers Another Place To Target This Known Cause Of Cancer

medicalnewstoday.com — “Since the mid-1990s, doctors have had the protein Mer in their sights - it coats the outside of cancer cells, transmitting signals inside the cells that aid their uncontrolled growth.A UView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 7:05 am By:

mnt_genetics MNT Genetics News Health News

In Leukemia, Discovery Of Mer Protein In Cancer Cells' Nuclei Offers Another Place To Target This Known Cause Of Cancer http://t.co/ruzi54SM

1 month ago...

Discovery of Mer protein in leukemia cells' nuclei may be new, druggable target

labspaces.net — “Since the mid-1990s, doctors have had the protein Mer in their sights – it coats the outside of cancer cells, transmitting signals inside the cells that aid their uncontrolled growth.View full resource at labspaces.net

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 4:00 pm By:

LabSpaces Brian Krueger Health News

Discovery of Mer protein in leukemia cells' nuclei may be new, druggable target - http://t.co/D9cbQrei

1 month ago...

Antidepressant could help the workings of anticancer drug used in leukemia

news-medical.net — “The study by scientists at the Institute of Cancer Research found that tranylcypromine (TCP) – which can be used to treat psychotic depressive states - can make cancer cells vulnerable to the effects of a vitamin A-derivative drug called ATRA.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 13, 2012 at 11:19 pm By:

Genetics_News News-Medical.Net Health News

Genetics News: Antidepressant could help the workings of anticancer drug used in leukemia: The study by scientis... http://t.co/3PnFxbgj

1 month ago...

Advertisement